DEFLORIAN, FRANCESCA
DEFLORIAN, FRANCESCA
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
2004 Colotta, V; Catarzi, D; Varano, F; Calabri, Fr; Lenzi, O; Filacchioni, G; Martini, C; Trincavelli, L; Deflorian, Francesca; Moro, Stefano
Application of a molybdenum and tungsten disulfide coating to improve tribological properties of orthodontic archwires
2019 Gracco, A.; Dandrea, M.; Deflorian, F.; Zanella, C.; De Stefani, A.; Bruno, G.; Stellini, E.
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A(3) adenosine receptor antagonists: Pyrazolo[4,3-e]1,2,4- triazolo[1,5-c]pyrimidine derivatives as a key study
2005 Moro, Stefano; Braiuca, P; Deflorian, Francesca; Ferrari, C; Pastorin, G; Cacciari, B; Baraldi, Pg; Varani, K; Borea, Pa; Spalluto, G.
Combining ligand-based and structure-based drug design in the virtual screening arena
2007 Moro, Stefano; Bacilieri, Magdalena; Deflorian, Francesca
Demystifying the three dimensional structure of G protein- coupled receptors (GPCRs) with the aid of molecular modeling
2003 Moro, Stefano; Deflorian, Francesca; Spalluto, G; Pastorin, G; Cacciari, B; Kim, Sk; Jacobson, Ka
G protein-coupled receptors as challenging druggable targets: insights from in silico studies
2006 Moro, Stefano; Bacilieri, Magdalena; Deflorian, Francesca; Spalluto, G.
Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity
2006 Moro, Stefano; Deflorian, Francesca; Bacilieri, Magdalena; Spalluto, G.
Novel strategies for the design of new potent and selective human A3 receptor antagonists: an update
2006 Moro, Stefano; Deflorian, Francesca; Bacilieri, Magdalena; G., Spalluto
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: a complete structure -activity profile.
2007 Cacciari, B; Bolcato, C; Spalluto, G; Klotz, Kn; Bacilieri, Magdalena; Deflorian, Francesca; Moro, Stefano
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A(3) and A(2B) adenosine receptor subtypes: A molecular modeling investigation
2003 Pastorin, G; DA ROS, T; Spalluto, G; Deflorian, Francesca; Moro, Stefano; Cacciari, B; Baraldi, Pg; Gessi, S; Varani, K; Borea, Pa
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists: influence of the N5 substituent on the affinity at the human A3 and A2B adenosine receptor subtypes.
2003 G., Pastorin; T., DA ROS; G., Spalluto; B., Cacciari; Moro, Stefano; Deflorian, Francesca; K., Varani; S., Gessi; P. A., Borea
Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies
2006 Colotta, V; Catarzi, D; Varano, F; Lenzi, O; Filacchioni, G; Costagli, C; Galli, A; Ghelardini, C; Galeotti, N; Gratteri, P; Sgrignani, J; Deflorian, Francesca; Moro, Stefano
Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: Design of new Gly/NMDA receptor antagonists as a key study
2007 Bacilieri, Magdalena; Varano, F.; Deflorian, Francesca; Marini, M.; Catarzi, D.; Colotta, V.; Filacchioni, G.; Galli, A.; Costagli, C.; Kaseda, C.; Moro, Stefano